OKUR

OnKure Therapeutics

2.865

+0.340+13.47%

After Hours: 2.865 0.000 0.00%16:15 11/06 EST

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE2.470/2.525

TODAY RANGE2.310-2.880

VOL555.82K

MARKET CAP116.04M

52 WEEK RANGE2.010-5.38

AVG VOL (3M)297.39K

% TURNOVER1.35%

TURNOVER--

P/E (TTM)-1.0356

% RANGE22.57%

EPS(TTM)-2.7665

P/E(FORWARD)-0.7539

P/B0.7357

BVPS3.894

DIVIDEND--

P/S--

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP96.62M

SHARES OUTSTANDING40.50M

NEXT EARNINGS--

FREE FLOAT33.72M

LOT SIZE1

EX-DATE10/07/2024

News

Press Releases

Financial Reports

Profile

Seeking Alpha·1d ago
OnKure Therapeutics GAAP EPS of -$0.36
Dow Jones·2d ago
Press Release: OnKure Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Highlights
Seeking Alpha·10/29 19:44
Russell 2000 estimated to drop 83 stocks in December rebalance - Stephens
Dow Jones·08/14 17:25
OnKure Therapeutics Price Target Cut to $14.00/Share From $30.00 by Oppenheimer
TipRanks·08/13 10:36
OnKure Reprices Underwater Stock Options to Boost Retention
Seeking Alpha·08/10 23:22
Recursion Pharmaceuticals: I'm Still Bearish Despite Recent Genentech News
TipRanks·08/06 03:00
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks·08/05 13:00
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Arrowhead Pharmaceuticals (ARWR), OnKure Therapeutics (OKUR) and Alnylam Pharma (ALNY)
Dow Jones·08/04 20:08
Press Release: OnKure Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights
TipRanks·07/22 12:30
Fourteen new option listings and one option delisting on July 22nd
Dow Jones·07/20 16:02
OnKure Therapeutics Price Target Cut to $21.00/Share From $27.00 by HC Wainwright & Co.
Dow Jones·07/20 16:02
OnKure Therapeutics Is Maintained at Buy by HC Wainwright & Co.
TipRanks·07/20 12:26
OnKure Therapeutics price target lowered to $21 from $27 at H.C. Wainwright
TipRanks·07/16 13:20
Analysts Conflicted on These Healthcare Names: Fractyl Health, Inc. (GUTS) and OnKure Therapeutics (OKUR)
TipRanks·07/15 23:35
OnKure Maintained at Buy as Strategy Shifts to Next-Gen PI3Kα Inhibitors; $16 Price Target Reaffirmed

Same Industry

Name/Symbol

Change%

Price

OKUR

REGN

GRDX

BNTX

UTHR

VRTX

SIGA

MRNA

CRL

MEDP

TLPH

ICLR

CBPO

IQV

MOLN

ARCT

GILD

PRAH

INCY

APVO

BSTC

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.